NCT00890123

Preoperative Intravenous Omega 3 Fatty Acids Administration in Elderly Patients Undergoing Hip Surgery

Preoperative Intravenous Omega 3 Fatty Acids Administration in Elderly Patients Undergoing Hip Surgery: A Prospective, Randomized, Open-label, Comparative Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Nizam's Institute of Medical Sciences University, India · Academic / Other
• Sex: All
• Age: 60 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The perioperative administration of n-3 fatty acids has been shown to lead to favorable effects on outcome in patients with severe surgical interventions by lowering the magnitude of inflammatory response and by modulating the immune response. No study with preoperative administration of IV omega 3 fatty acids as a part of total parenteral nutrition (TPN) or monotherapy with it to demonstrate its effects on inflammatory and immune response has been conducted. So, this study has been planned to judge the inflammatory response of preoperative monotherapy with IV omega 3 fatty acids in elderly patients undergoing hip surgery considering the hyper-inflammation associated with this type of surgery in elderly patients.

Conditions

• Hip Surgery

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Omegaven-IV FO	Will receive IV Omega 3 fatty acids (Omegaven®) for 3 pre operative days

Timeline

• Start date: 2009-04-01
• Primary completion: 2010-04-01
• Completion: 2010-12-01
• First posted: 2009-04-29
• Last updated: 2014-10-02

Locations

1 site across 1 country: India